Sparing of suppressor cells: a critical action of cyclosporine.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D003520:Cyclophosphamide / Q000494:pharmacology; D003524:Cyclosporins / Q000627:therapeutic use*; D006084:Graft Rejection; D006086:Graft vs Host Disease / Q000517:prevention & control; D016027:Heart Transplantation; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D007165:Immunosuppression Therapy; D007694:Killer Cells, Natural / Q000187:drug effects; D008213:Lymphocyte Activation / Q000187:drug effects; D008222:Lymphokines / Q000378:metabolism; D011952:Receptors, Concanavalin A / Q000378:metabolism; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects*; D014184:Transplantation, Homologous
D003524:Cyclosporins; D008222:Lymphokines; D011952:Receptors, Concanavalin A; D003520:Cyclophosphamide